General
Preferred name
THIAZOLIDINEDIONE
Synonyms
2,4-thiazolidinedione ()
Thiazolidine-2,4-Dione ()
NSC-6745 ()
P&D ID
PD058879
CAS
2295-31-0
Tags
available
drug
Drug indication
Alzheimer disease
diabetes mellitus
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
2,4-Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes mellitus. It is a PPARγ (Peroxisome proliferator-activated receptor, gamma) agonist, IC50 = 0.2 µM. It also inhibits GSK-3 (Glycogen synthase kinase-3 beta), IC50 = 100µM.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
ChEMBL Drugs
DrugBank
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Molecular Weight
116.99
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
0
cLogP
-0.03
TPSA
46.17
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
5.0
QED
0.48
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
PPAR
Source data
